Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Malignant pleural mesothelioma causes the greatest societal burden of all the asbestos-related diseases. Progress in better understanding tumour biology will be facilitated by the availability of quality-assured annotated tissue. MesobanK has been created to establish a bioresource of pleural mesothelioma tissue linked to detailed anonymised clinical data. When complete, the bioresource will comprise a 750-patient tissue microarray and prospectively collected tissue, blood and pleural fluid from 300 patients with mesothelioma. Twenty-six new cell lines have also been developed. MesobanK meets all appropriate ethical and regulatory procedures and has recently opened to requests for tissue and data.

Original publication

DOI

10.1136/thoraxjnl-2015-207496

Type

Journal article

Journal

Thorax

Publication Date

04/2016

Volume

71

Pages

380 - 382

Keywords

Asbestos Induced Lung Disease, Histology/Cytology, Mesothelioma, Pleural Disease, Biological Specimen Banks, Biomedical Research, Foundations, Humans, International Cooperation, Lung Neoplasms, Mesothelioma, Pleural Neoplasms, United Kingdom